123 related articles for article (PubMed ID: 3036401)
21. CA 125 and survival in ovarian cancer: preliminary communication.
Parker D; Patel K; Alred EJ; Harnden-Mayor P; Naylor B
J R Soc Med; 1988 Jan; 81(1):22. PubMed ID: 3422695
[TBL] [Abstract][Full Text] [Related]
22. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy of germinal tumors.
Solomon J; Steinfeld JL; Bateman JR
Cancer; 1967 May; 20(5):747-50. PubMed ID: 4290386
[No Abstract] [Full Text] [Related]
24. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
Ishiwata I; Ishiwata C
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
[No Abstract] [Full Text] [Related]
25. CA 15-3 serum levels in ovarian cancer.
Scambia G; Benedetti Panici P; Baiocchi G; Perrone L; Greggi S; Di Roberto P; Mancuso S
Oncology; 1988; 45(3):263-7. PubMed ID: 3163419
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors].
Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of CA-125 in patients with endometriosis: a preliminary report.
Giudice LC; Jacobs A; Pineda J; Bell CE; Lippmann L
Fertil Steril; 1986 Jun; 45(6):876-8. PubMed ID: 3458595
[TBL] [Abstract][Full Text] [Related]
28. High-Dose Chemotherapy in a Late Relapse, Platinum-Refractory Nonseminomatous Germ Cell Tumor.
Connell BJ; Patel MJ; Tretter CG
Clin Genitourin Cancer; 2016 Aug; 14(4):e441-3. PubMed ID: 27055370
[No Abstract] [Full Text] [Related]
29. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
[TBL] [Abstract][Full Text] [Related]
30. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
Cruickshank DJ; Fullerton WT; Klopper A
Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
32. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
[TBL] [Abstract][Full Text] [Related]
34. Multiple antigens as marker substances in germinal tumors of the testis.
Wahren B; Alpert E; Esposti P
J Natl Cancer Inst; 1977 Mar; 58(3):489-98. PubMed ID: 65476
[TBL] [Abstract][Full Text] [Related]
35. CA-125 monitoring during chemotherapy for ovarian cancer.
Martoni A; Bellucco A; Marabini A; Orlandi C; Platé L; Bianchi D; Pannuti F
Int J Biol Markers; 1986; 1(3):121-8. PubMed ID: 3480916
[TBL] [Abstract][Full Text] [Related]
36. Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and controls: a preliminary report of the use of the NB12123 and CA 125 radioimmunoassays alone and in combination.
Knauf S; Bast RC
Int J Biol Markers; 1988; 3(2):75-81. PubMed ID: 3243980
[TBL] [Abstract][Full Text] [Related]
37. [Immune histochemical demonstration of tumor-associated antigens in testicular germ cell tumors].
Jacobsen GK; Jacobsen M; Clausen PP
Ugeskr Laeger; 1982 May; 144(18):1300-3. PubMed ID: 6181597
[No Abstract] [Full Text] [Related]
38. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
[TBL] [Abstract][Full Text] [Related]
39. Ovarian cancer: the prognostic value of the serum half-life of CA125 during induction chemotherapy.
van der Burg ME; Lammes FB; van Putten WL; Stoter G
Gynecol Oncol; 1988 Jul; 30(3):307-12. PubMed ID: 3164697
[TBL] [Abstract][Full Text] [Related]
40. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]